As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Pharmaxis will likely underperform.
The median price of Pharmaxis for the period between Wed, Apr 24, 2013 and Fri, May 24, 2013 is 0.15 with a coefficient of variation of 10.49. The daily time series for the period is distributed with a sample standard deviation of 0.02, arithmetic mean of 0.15, and mean deviation of 0.01. The Stock did not receive any noticable media coverage during the period.
Pharmaxis Ltd [PXS] is traded on Australian Securities Exchange in Australia. It is located in Frenchs Forest, NSW and employs 17 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 44.8 M. Pharmaxis Ltd operates under Healthcare sector and is part of Drug Manufacturers - Major industry. This company has 309 M outstanding shares.
Pharmaxis Ltd, a pharmaceutical company, engages in the research, development, and commercialization of human healthcare solutions for the treatment and management of respiratory diseases in the United States, Europe, Australia, and southeast Asia. more
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-0.53% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Australian
